Kyntra Bio KYNB
NASDAQ KYNB
$3.29 -0.20 (-5.73%)
As of: Nov 16, 2026 · 11:42 AM EST

Kyntra Bio (KYNB) Construction in Progress (2016 - 2021)

Updated

Analysis

Kyntra Bio (KYNB) Construction in Progress (2016 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,296.59 Bn 1,270.20 Bn 20.46 Bn -
2 Johnson & Johnson 686.90 Bn 606.77 Bn 17.30 Bn -
3 AbbVie 526.97 Bn 494.98 Bn 13.12 Bn -
4 Merck 362.70 Bn 325.64 Bn 13.19 Bn -
5 Novartis Ag 313.69 Bn 286.93 Bn - -
6 Astrazeneca 286.96 Bn 260.48 Bn 13.26 Bn -
7 Amgen 254.14 Bn 205.80 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.72 Bn 6.73 Bn -
9 Pfizer 165.27 Bn 112.63 Bn 12.56 Bn -
10 Kyntra Bio 13.70 Mn -394.24 Mn 1.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 1.92 Mn
Jun 30, 2021 1.41 Mn
Mar 31, 2021 228,000.00
Dec 31, 2020 760,000.00
Sep 30, 2020 1.51 Mn
Jun 30, 2020 1.23 Mn
Mar 31, 2020 1.21 Mn
Dec 31, 2019 1.79 Mn
Sep 30, 2019 2.33 Mn
Jun 30, 2019 1.89 Mn
Mar 31, 2019 607,000.00
Dec 31, 2018 367,000.00
Dec 31, 2017 10.40 Mn
Dec 31, 2016 109,000.00
API Access

Kyntra Bio Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=KYNB&period=max&api_key=YOUR_API_KEY